Hypoglycemic agents for non-alcoholic fatty liver disease with type 2 diabetes mellitus: A protocol for systematic review and network meta-analysis

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in Western countries, and strongly associated with type 2 diabetes mellitus (T2DM). Several studies have shown that hypoglycemic agents are effective for NAFLD combined with T2DM. However, there i...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Su-Tong, Su, Kai-Qi, Zhang, Li-Hui, Liu, Ming-Hao, Zhao, Wen-Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593046/
https://www.ncbi.nlm.nih.gov/pubmed/32769900
http://dx.doi.org/10.1097/MD.0000000000021568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593046/
https://www.ncbi.nlm.nih.gov/pubmed/32769900
http://dx.doi.org/10.1097/MD.0000000000021568

Ejemplares similares